MNPR

Monopar Therapeutics

$54.10+0.08 (0.15%)
Price
MA20
Insider buy
Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5

Monopar Therapeutics (MNPR) is a publicly traded company with 5 insider transactions disclosed via SEC Form 4 in the past 90 days, involving 3 unique insiders. All data below is sourced directly from public SEC EDGAR Form 4 filings.

Latest Insider Transactions

Showing 10 of 42 transactions (past 365 days)

MNPR
CEO
Tax Payment
$108K
Robinson Chandler1,972 shares @ $54.79
Filed 2026-04-02Trade 2026-03-31
MNPR
CEO
Exercise Conversion
$0
Robinson Chandler6,732 shares @ $0.00
Filed 2026-04-02Trade 2026-03-31
MNPR
COO
Tax Payment
$86.1K
Cittadine Andrew1,571 shares @ $54.79
Filed 2026-04-02Trade 2026-03-31
MNPR
COO
Exercise Conversion
$0
Cittadine Andrew3,514 shares @ $0.00
Filed 2026-04-02Trade 2026-03-31
MNPR
CCSO
Award
$2.6M
Rodriguez Susan48,728 shares @ $53.47
Filed 2026-03-04Trade 2026-03-02
MNPR
Other
Award
$0
Rioux Patrice2,000 shares @ $0.00
Filed 2026-01-05Trade 2026-01-01
MNPR
COO
Exercise Conversion
$0
Cittadine Andrew4,326 shares @ $0.00
Filed 2026-01-05Trade 2025-12-31
MNPR
COO
Tax Payment
-$123.4K
Cittadine Andrew1,889 shares @ $65.30
Filed 2026-01-05Trade 2025-12-31
MNPR
CEO
Exercise Conversion
$0
Robinson Chandler8,724 shares @ $0.00
Filed 2026-01-05Trade 2025-12-31
MNPR
CEO
Tax Payment
-$167K
Robinson Chandler2,558 shares @ $65.30
Filed 2026-01-05Trade 2025-12-31

Want to see more transactions?

Sign up for free to unlock more insider transactions and create watchlists.

Cluster Buy Signals →All Insider Signals →Top Insider Buying →